Khalid Shah

Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

Steven H. Liang, Y. S. Zhang, S. Smirnakis, 2022, Nature Communications.

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

H. Wakimoto, Mohammad N. Alomary, D. Bhere, 2021, Cells.

Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization

Z. H. Gümüş, Tunc Morova, D. Bhere, 2021, Oncogene.

Immunotherapy in hematological malignancies: recent advances and open questions.

Abdulaziz M. Almalik, Rana Abou-Khalil, Essam A. Tawfik, 2021, Immunotherapy.

Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases

U. Mahmood, A. Brownell, C. Farrar, 2023, Cancer Gene Therapy.

Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors

Lucía Moreno-Lama, Wanlu Li, Touraj Aligholipour Farzani, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus

A. Alkayyal, Khalid Shah, Marco Cacciabue, 2023, Frontiers in Immunology.

Meningeal lymphatics and their role in CNS disorder treatment: moving past misconceptions

Reza Abdi, Khalid Shah, Longsha Liu, 2023, Frontiers in neuroscience.

Next-Generation Immunotherapies for Brain Metastatic Cancers.

Wanlu Du, Nobuhiko Kanaya, Yohei Kitamura, 2021, Trends in cancer.